Results: 26
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1445, doi. 10.1038/leu.2010.101
- By:
- Publication type:
- Article
Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Response to letter by Pulsipher et al.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis.
- Published in:
- 2010
- By:
- Publication type:
- Letter
CBFA2T2 and C20orf112: two novel fusion partners of RUNX1 in acute myeloid leukemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1422, doi. 10.1038/leu.2010.127
- By:
- Publication type:
- Article
Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1476, doi. 10.1038/leu.2010.117
- By:
- Publication type:
- Article
Differential expression of NF-κB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1487, doi. 10.1038/leu.2010.118
- By:
- Publication type:
- Article
Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Molecular signature of adult bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast/germ line origin.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1450, doi. 10.1038/leu.2010.121
- By:
- Publication type:
- Article
Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1429, doi. 10.1038/leu.2010.130
- By:
- Publication type:
- Article
Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1462, doi. 10.1038/leu.2010.133
- By:
- Publication type:
- Article
Bone marrow fibrosis and vascular density lack prognostic significance in childhood acute lymphoblastic leukaemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Functional differences between myeloid leukemia-initiating and transient leukemia cells in Down's syndrome.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 8, p. 1506, doi. 10.1038/leu.2010.137
- By:
- Publication type:
- Article
Polymorphisms in the base excision repair pathway and graft-versus-host disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Retraction. A microarray study of altered gene expression in Ara-C resistance in acute myeloid leukemia.
- Published in:
- 2010
- By:
- Publication type:
- corrected article
Deoxycytidine kinase is downregulated in Ara-C-resistant acute myeloid leukemia murine cell lines.
- Published in:
- 2010
- By:
- Publication type:
- Letter